New AI-Based Solutions Create Possibility for Early Cancer Screening

Two new Artificial Intelligence- (AI) based products released at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, USA, could create possibility for large-scale early cancer screening globally.

YITU Technology (Shanghai, China), which offers a range of AI-based medical solutions and products, launched two new products, Intelligent Diagnostic and Treatment Platform for Cancer Screening and CARE.AI Intelligent 4D Imaging System for Chest CT.


Intelligent Diagnostic and Treatment Platform for Cancer Screening is a platform that relies on YITU Healthcare's disease-centered massive multi-modal medical data to provide doctors with imaging detection, lesion analysis, clinical decision-making assistance, patient management and other services. For a long time now, it has been difficult to widely promote large-scale early screening of diseases, especially cancer screening, due to limited high-quality medical resources. The emergence of high-level medical AI has now made it possible for AI systems to assist doctors in providing medical services to a certain extent and offers the possibility for large-scale early screening of tumors.

The CARE.AI Intelligent 4D Imaging System for Chest CT is the first AI system in the world to enable detection of pulmonary nodules and allow for real-time imaging of a wide variety of other lesions. It is the world's first product that can perform imaging-based diagnosis for all types of lesions such as patchy shadow, stripe shadow and cystic shadow, and provide information sign analysis and diagnosis for accurate prediction and evaluation. The system realizes the full-dimensional detection of lesions for chest CT imaging, improves the functions of medical AI and promotes its application in clinical practice. Together with other cancer screening solutions, it can greatly reduce the workload of radiologists, become a clinical assistant to radiologists, and provide the possibility for large-scale early cancer screening worldwide.

"Medical AI products with advanced and reliable performance, which meet clinical needs and can be quickly replicated, are great creations in human history, and China is making rapid progress in this field," said Dr. Cathy Fang, Vice President of YITU Healthcare. "YITU's series of AI products have been widely applied in more than 200 Grade-A tertiary hospitals throughout China and cover the regional medical centers at the municipal and county levels in numerous provinces and cities. We look forward to bringing advanced AI products to all parts of the world and working towards promoting the improvement of human health care level."

Related Links:
YITU Technology